AI English summary of an SEC filing — figures as filed

The company said the Compensation Committee of its Board of Directors granted a one-time restricted stock unit award of 34,634 shares to James Hippel, Executive Vice President and Chief Financial Officer, on October 30, 2024.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Nov 5, 2024Period of report Oct 30, 2024Summary published (UTC) Oct 25, 2026

Key points

AI summary

The company said the Compensation Committee of its Board of Directors granted a one-time restricted stock unit award of 34,634 shares to James Hippel, Executive Vice President and Chief Financial Officer, on October 30, 2024.
It said the restricted stock unit award was made under the amended 2020 Equity Incentive Plan.
The company also said the award vests in equal installments on the first three anniversaries of the grant date, subject to Mr. Hippel's continued service with the company and the terms of the plan and the underlying award agreement.
Bio-Techne said the award was granted for retention purposes and took into account stock options that Mr. Hippel forfeited due to a stock plan administrative error in recording the expiration date.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

One-time RSU award of 34,634 shares

The company said the Compensation Committee of its Board of Directors granted a one-time restricted stock unit award of 34,634 shares to James Hippel, Executive Vice President and Chief Financial Officer, on October 30, 2024.

Source · Based on the filing body and exhibits

Basis in the 2020 Equity Incentive Plan

It said the restricted stock unit award was made under the amended 2020 Equity Incentive Plan.

Source · Based on the filing body and exhibits

Equal vesting over 3 years from grant date

The company also said the award vests in equal installments on the first three anniversaries of the grant date, subject to Mr. Hippel's continued service with the company and the terms of the plan and the underlying award agreement.

Source · Based on the filing body and exhibits

Retention purpose and forfeited stock options considered

Bio-Techne said the award was granted for retention purposes and took into account stock options that Mr. Hippel forfeited due to a stock plan administrative error in recording the expiration date.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.